RHHVF (Roche Holding AG) Short Interest


RHHVF Roche Holding AG RHHVF
81 GF Score
Price $411.84
GF Value $331.52
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Roche Holding AG Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

RHHVF vs LLY, JNJ, ABBV: Short Interest Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roche Holding AG Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's Short Interest distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's Short Interest falls into.


RHHVF
81GF Score
Roche Holding AG RHHVF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (RHHVF) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of $411.84 is trading 24.2% above its estimated GF Value™ of $331.52. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for RHHVF:

  • Short Interest:
  • GF Value™: $331.52 vs. price of $411.84 (24.2% above fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the RHHVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
81GF Score

Get the complete analysis for RHHVF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$411.84
Price
$331.52
GF Value